chr9-21968734-C-G

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP6BS1BS2

The ENST00000498124.1(CDKN2A):​c.495G>C​(p.Arg165Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000553 in 1,536,164 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R165T) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00019 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000040 ( 0 hom. )

Consequence

CDKN2A
ENST00000498124.1 missense

Scores

2
12

Clinical Significance

Likely benign no assertion criteria provided B:2O:1

Conservation

PhyloP100: -1.27

Publications

5 publications found
Variant links:
Genes affected
CDKN2A (HGNC:1787): (cyclin dependent kinase inhibitor 2A) This gene generates several transcript variants which differ in their first exons. At least three alternatively spliced variants encoding distinct proteins have been reported, two of which encode structurally related isoforms known to function as inhibitors of CDK4 kinase. The remaining transcript includes an alternate first exon located 20 Kb upstream of the remainder of the gene; this transcript contains an alternate open reading frame (ARF) that specifies a protein which is structurally unrelated to the products of the other variants. This ARF product functions as a stabilizer of the tumor suppressor protein p53 as it can interact with, and sequester, the E3 ubiquitin-protein ligase MDM2, a protein responsible for the degradation of p53. In spite of the structural and functional differences, the CDK inhibitor isoforms and the ARF product encoded by this gene, through the regulatory roles of CDK4 and p53 in cell cycle G1 progression, share a common functionality in cell cycle G1 control. This gene is frequently mutated or deleted in a wide variety of tumors, and is known to be an important tumor suppressor gene. [provided by RefSeq, Sep 2012]
CDKN2A Gene-Disease associations (from GenCC):
  • melanoma, cutaneous malignant, susceptibility to, 2
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • melanoma-pancreatic cancer syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • familial atypical multiple mole melanoma syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • melanoma and neural system tumor syndrome
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP6
Variant 9-21968734-C-G is Benign according to our data. Variant chr9-21968734-C-G is described in ClinVar as Likely_benign. ClinVar VariationId is 133881.Status of the report is no_assertion_criteria_provided, 0 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00019 (29/152332) while in subpopulation AFR AF = 0.000625 (26/41580). AF 95% confidence interval is 0.000438. There are 0 homozygotes in GnomAd4. There are 15 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 29 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000498124.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CDKN2A
NM_000077.5
MANE Select
c.458-492G>C
intron
N/ANP_000068.1
CDKN2A
NM_058195.4
MANE Plus Clinical
c.*102-492G>C
intron
N/ANP_478102.2
CDKN2A
NM_001195132.2
c.495G>Cp.Arg165Ser
missense
Exon 3 of 4NP_001182061.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CDKN2A
ENST00000498124.1
TSL:1
c.495G>Cp.Arg165Ser
missense
Exon 3 of 4ENSP00000418915.1
CDKN2A
ENST00000304494.10
TSL:1 MANE Select
c.458-492G>C
intron
N/AENSP00000307101.5
CDKN2A
ENST00000579755.2
TSL:1 MANE Plus Clinical
c.*102-492G>C
intron
N/AENSP00000462950.1

Frequencies

GnomAD3 genomes
AF:
0.000191
AC:
29
AN:
152214
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000627
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.0000892
AC:
12
AN:
134580
AF XY:
0.0000409
show subpopulations
Gnomad AFR exome
AF:
0.000622
Gnomad AMR exome
AF:
0.000245
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000378
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000405
AC:
56
AN:
1383832
Hom.:
0
Cov.:
32
AF XY:
0.0000293
AC XY:
20
AN XY:
682862
show subpopulations
African (AFR)
AF:
0.00111
AC:
35
AN:
31594
American (AMR)
AF:
0.000196
AC:
7
AN:
35700
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25182
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35734
South Asian (SAS)
AF:
0.0000126
AC:
1
AN:
79236
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
33896
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5696
European-Non Finnish (NFE)
AF:
0.00000649
AC:
7
AN:
1078884
Other (OTH)
AF:
0.000104
AC:
6
AN:
57910
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
4
8
11
15
19
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000190
AC:
29
AN:
152332
Hom.:
0
Cov.:
32
AF XY:
0.000201
AC XY:
15
AN XY:
74486
show subpopulations
African (AFR)
AF:
0.000625
AC:
26
AN:
41580
American (AMR)
AF:
0.000131
AC:
2
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68024
Other (OTH)
AF:
0.000473
AC:
1
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.515
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000130
Hom.:
0
Bravo
AF:
0.000366
ExAC
AF:
0.0000560
AC:
1

ClinVar

ClinVar submissions as Germline

Significance:Likely benign
Revision:no assertion criteria provided
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
CDKN2A-related disorder (1)
-
-
1
Melanoma-pancreatic cancer syndrome (1)
-
-
-
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.21
BayesDel_addAF
Benign
-0.40
T
BayesDel_noAF
Benign
-0.41
CADD
Benign
0.15
DANN
Benign
0.72
Eigen
Benign
-0.81
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.075
N
LIST_S2
Benign
0.44
T
M_CAP
Benign
0.015
T
MetaRNN
Benign
0.018
T
MetaSVM
Benign
-0.70
T
PhyloP100
-1.3
PROVEAN
Benign
-0.12
N
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Vest4
0.15
MVP
0.95
MPC
0.45
ClinPred
0.011
T
GERP RS
-3.7
gMVP
0.48
Mutation Taster
=55/45
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.23
Details are displayed if max score is > 0.2
DS_AG_spliceai
0.23
Position offset: 37

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs527814073; hg19: chr9-21968733; COSMIC: COSV58691828; COSMIC: COSV58691828; API